Top Contributors Empowering Healthcare | MD Tech Review

EUROPE

Contributors

DATA SCIENCE IN OUTPATIENT ACCESS MANAGEMENT

Adrian Keister, Sr. Data Science Analyst at Mayo Clinic

How One Unique Certified Home Health Agency Formed a Special Relationship with One World-Class New York City Hospital System

Jack Bron, VP of Strategic Partnerships, Centers Choice Home Care

During this COVID-19 pandemic, whenever nurses found it difficult to come to work, NYU always knew Revival Home...

Day in the Life of COVID Reporting

Amber Theel, System Director - Patient Safety and Quality, Adventist Health

The end game is to understand the disease, its prevalence, the resources needed to keep everyone safe and hopefully...

Healthcare Quality: Who is in charge and why?

Steve Tierney MD, Sr. Medical Director Quality Improvement, South central Foundation

Every healthcare organization has a quality department.

Managed Care World without Prior Authorizations is a Win-Win for All Parties Lessons reinforced by COVID-19 & the "No Auth" Business Model

Franklin Segura, Vice President of Managed Care, Centers Health Care

Typically, when a provider and health plan agree to go with the no prior authorization methodology, the health plan will require a monthly summary of the cases the provider has accepted.

Revamping Workflow in Pharma Industry with Technology

Bozidar Jovicevic, VP, Global Head of Digital Therapeutics, Sanofi [EPA:SAN]

Technology has aided the pharma and life sciences industry in employing genomics and artificial intelligence (AI) for speeding up drug R&D course

Progressive Innovation Improving Patient Outcomes

Emanuele Degortes, Head of Patient, Innovation and Access Policy, Vifor Pharma

Companies are starting to realise the impact that patients and patient associations can have along the entire life cycle of their products, from regulatory filing, to market access

How AI will change translational research in pharma clinical development

James Cai, Head of Data Science, Roche

To fully realize the power of AI, it is important for both pharma and academia to invest in research at the intersection of AI and biomedicine. It is also imperative to systematically generate high quality, properly labeled data.

The Changing Role of CIO in the Biopharmaceutical Industry

Andy Newsom, CIO, CSL Behring

As IT leaders, CIO needs to ensure that the IT organization is led by business, and not driven by technology

How Technology Is Disrupting the Pharma and Life Sciences Industry

Colin Boatwright, CIO, Ironshore Pharmaceuticals Inc

The Pharma and Life Sciences have a reputation of lagging behind in certain technology areas, either because of fears around regulatory concerns or the cost of migrating legacy applications.